Ko Wonmin, Lee Hwan, Kim Nayeon, Jo Hee Geun, Woo Eun-Rhan, Lee Kyounghoon, Han Young Seok, Park Sang Rul, Ahn Ginnae, Cheong Sun Hee, Lee Dong-Sung
Department of Marine Bio-Food Sciences, Chonnam National University, Yeosu 59626, Korea.
College of Pharmacy, Chosun University, Dong-gu, Gwangju 61452, Korea.
Antioxidants (Basel). 2021 May 27;10(6):859. doi: 10.3390/antiox10060859.
is used as a traditional medicinal agent and exhibits various pharmacological effects. In this study, we found that the 70% EtOH extract contained 34.37 ± 0.75 μg/mg fucosterol. We tested the antioxidant activities of the 70% EtOH extracts and their fractions. The CHCl-soluble fraction showed the strongest DPPH and ABTS radical scavenging activities. Next, we evaluated the anti-neuroinflammatory effects of on lipopolysaccharide (LPS)-stimulated BV2 cells. Pretreatment with the extract and fractions suppressed LPS-induced production of nitric oxide (NO) in BV2 cells. The 70% EtOH, CHCl-soluble fraction, and water-soluble fraction inhibited the production of prostaglandin E2, interleukin-6, and tumor necrosis factor-α, as well as markedly blocking LPS-induced expression of inducible NO synthase and cyclooxygenase-2 via inactivation of the nuclear factor-kappa B pathway. In addition, the CHCl-soluble fraction showed the most remarkable heme oxygenase (HO)-1 expression effects and increased nuclear erythroid 2-related factor translocation in the nucleus. In HT22 cells, the CHCl-soluble fraction inhibited cell damage and ROS production caused by glutamate via the regulation of HO-1. Therefore, CHCl-soluble fractions of can attenuate oxidative action and neuroinflammatory responses via HO-1 induction, demonstrating their potential in the treatment of neuroinflammatory diseases.
它被用作传统药物并具有多种药理作用。在本研究中,我们发现70%乙醇提取物中含有34.37±0.75μg/mg岩藻甾醇。我们测试了70%乙醇提取物及其馏分的抗氧化活性。氯仿可溶馏分表现出最强的DPPH和ABTS自由基清除活性。接下来,我们评估了其对脂多糖(LPS)刺激的BV2细胞的抗神经炎症作用。提取物及其馏分预处理可抑制LPS诱导的BV2细胞中一氧化氮(NO)的产生。70%乙醇、氯仿可溶馏分和水溶性馏分抑制前列腺素E2、白细胞介素-6和肿瘤坏死因子-α的产生,并通过核因子-κB途径失活显著阻断LPS诱导的诱导型NO合酶和环氧化酶-2的表达。此外,氯仿可溶馏分表现出最显著的血红素加氧酶(HO)-1表达效应,并增加了核内红细胞2相关因子的易位。在HT22细胞中,氯仿可溶馏分通过调节HO-1抑制谷氨酸引起的细胞损伤和活性氧产生。因此,其氯仿可溶馏分可通过诱导HO-1减轻氧化作用和神经炎症反应,表明它们在治疗神经炎症性疾病方面的潜力。